GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » Additional Paid-In Capital

Innovita Biological Technology Co (SHSE:688253) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co Additional Paid-In Capital?


Innovita Biological Technology Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0.0 Mil) to Dec. 2024 (¥1,003.6 Mil) but then stayed the same from Dec. 2024 (¥1,003.6 Mil) to Mar. 2025 (¥0.0 Mil).

Innovita Biological Technology Co's annual additional paid-in capital stayed the same from Dec. 2022 (¥995.5 Mil) to Dec. 2023 (¥995.5 Mil) but then increased from Dec. 2023 (¥995.5 Mil) to Dec. 2024 (¥1,003.6 Mil).


Innovita Biological Technology Co Additional Paid-In Capital Historical Data

The historical data trend for Innovita Biological Technology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co Additional Paid-In Capital Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 228.80 229.07 995.53 995.53 1,003.58

Innovita Biological Technology Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 995.53 - 1,003.58 -

Innovita Biological Technology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Innovita Biological Technology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines